Observational studyBMC medical imaging2026
Deep learning-based neuroanatomical profiling reveals population-specific brain changes in multiple sclerosis: a large-scale Middle Eastern study.
Observational study in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMultiple sclerosis (MS) affects 2.8 million individuals worldwide, with Middle Eastern populations remaining underrepresented in neuroimaging research despite elevated regional prevalence rates. Large-scale comparative studies between MS patients and healthy controls (HC) are essential for characterizing disease-specific brain changes and establishing normative biomarkers. This study aimed to perform comprehensive statistical characterization of brain structural changes in MS patients compared to HC using automated deep learning-based segmentation, establishing population-specific reference ranges for a Middle Eastern cohort.
methodsThis retrospective observational study analyzed 1,381 subjects (1,000 HC, 381 MS patients) from Northwest Iran. Four deep learning architectures were evaluated on multi-center training data (local cohort plus MSSEG dataset), with U-Net selected for automated FLAIR sequence segmentation. Neuroanatomically-informed lesion classification identified periventricular, deep, and juxtacortical white matter hyperintensities. Statistical analyses employed age group- and gender-stratified comparisons with comprehensive correlation assessments across ventricular and lesion load measures.
resultsU-Net achieved optimal segmentation performance (DSC = 88.8%, HD95 = 2.8 mm), supporting its selection for population-level analysis. Compared to healthy controls, MS patients exhibited markedly elevated structural burden across all age strata: ventricular load was 1.7-fold higher (normalized ratios: 1.39%→2.37%; t = - 18.92, Cohen's d = 1.139) and white matter lesion load was 2.4-fold higher (normalized ratios: 0.315%→0.749%; U = 11,963.0, rank-biserial r = 0.310), both with p < 10⁻⁶. Among lesion subtypes, periventricular lesions predominated (53.91 ± 20.62% of total burden), while anatomical distribution patterns showed no significant gender differences. Age-related structural changes were more pronounced in MS patients than in controls, with stronger correlations observed for both ventricular load (r = 0.403, p = 2.50 × 10⁻¹⁶) and lesion load (r = 0.266, p = 1.33 × 10⁻⁷).
conclusionsThis study provides preliminary population-specific reference ranges for MS neuroimaging biomarkers in Middle Eastern populations, revealing lesion accumulation patterns with periventricular predominance. The automated segmentation and statistical framework address gaps in global MS research demographics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.